Biotech Co.'s Shares Gain 32% After Posting Meaningful Renal Response Rates in Ph. 2 Lupus Study
Source: Streetwise Reports (11/16/2021)
Shares of Kezar Life Sciences Inc. rose to a new 52-week high after the company reported promising interim results from its Phase 2 trial of KZR-616 in patients with lupus nephritis.
read more >
EyePoint Pharma Reduces Wet AMD Treatment Burden by 79% after 6 Mo.'s in Phase 1 Trial
Source: Streetwise Reports (11/15/2021)
Shares of EyePoint Pharmaceuticals Inc. reached a new 52-week intraday high after the company reported positive data from its Phase 1 DAVIO study of EYP-1901 in Wet AMD and announced plans to move forward to additional Phase 2 clinical trials in 2022.
read more >
This Tech Trailblazer Is Recycling Platinum & Palladium From Catalytic Converters
Source: Streetwise Reports (11/13/2021)
Small tech company Mineworx has partnered with a Tennessee recycling company to extract platinum and palladium from diesel catalytic converters in a ground-breaking method that bypasses smelting, historically a major polluter.
read more >
Liquid Avatar Leverages Blockchain Tech for Age Verification & NFTs
Source: Streetwise Reports (11/13/2021)
In a recent conversation with Streetwise Reports, David Lucatch, CEO and president of Liquid Avatar, talked about the company's multifaceted approach to bringing blockchain technology to people's everyday experiences and transactions.
read more >
Contakt World Technologies Partnership Will Help Satisfy Demand for Vaccine Passport Technology
Source: Streetwise Reports (11/12/2021)
Contakt World plans to build a diversified health technology SaaS platform and address inequity of health access through technology.
read more >